Journals / Neurological sciences and neurophysiology (Online) / 2021 / Cilt: 38 - Sayı: 1

Balance and Gait Disturbances and Quality of Life in Patients with Idiopathic Parkinson’s Disease and Progressive Supranuclear Palsy

Hastalarda Denge ve Yürüyüş Bozuklukları ve Yaşam Kalitesi İdiyopatik Parkinson Hastalığı ve Progresif Supranükleer Palsi

Pages
45–49
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Balance, gait, idiopathic Parkinson’s disease, progressive supranuclear palsy, quality of life

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study is to compare the balance, gait, and quality of life of patients with idiopathic Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and healthy controls (HCs).
📊
Key Findings & Data:Materials and Methods: The present study included 26 patients with PD, 14 patients with PSP, and 22 HCs.
💡
Conclusion & Impact:Keywords: Balance, gait, idiopathic Parkinson’s disease, progressive supranuclear palsy, quality of life
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study is to compare the balance, gait, and quality of life of patients with idiopathic Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and healthy controls (HCs). Materials and Methods: The present study included 26 patients with PD, 14 patients with PSP, and 22 HCs. The Berg Balance Scale (BBS), Dynamic Gait Index (DGI), and the Turkish version of Mini‑Mental State Examination (MMSE) were administered to all participants. The Parkinson ’s disease questionnaire (PDQ‑39) and Unified PD Rating Scale were evaluated only among patients with PD and PSP. Results: There was a significant difference between PD and PSP in terms of BBS, DGI, and all variables of PDQ‑39 except “social support” (P < 0.05). Although a significant difference was found between patients with PSP and HCs in the BBS and DGI, there was no significant difference between patients with PD and HCs in the DGI and BBS. Further, the BBS and DGI were strongly correlated regarding the “mobility” and “activities of daily living” variables of the PDQ‑39 and moderately correlated in terms of “total scores of PDQ‑39,” “stigma,” and “communication” subscores. The MMSE was moderately associated with “total scores of PDQ‑39” and the “mobility” subscore. Conclusion: This study demonstrated a significant deterioration in balance, gait, and the quality of life in patients with PSP compared with PD and HCs. However, there was no difference between patients with PD and HCs. Keywords: Balance, gait, idiopathic Parkinson’s disease, progressive supranuclear palsy, quality of life

Özet

Amaç: Bu çalışmanın amacı, vücudun dengesini, yürüyüşünü ve kalitesini karşılaştırmaktır. idiyopatik Parkinson hastalığı (PD), ilerleyici supranükleer hastalığı olan hastaların yaşamı felç (PSP) ve sağlıklı kontroller (HC'ler). Gereç ve Yöntem: Mevcut çalışmaya PD'li 26 hasta, PSP'li 14 hasta ve 22 SK dahil edildi. Berg Denge Ölçeği (BBS), Dinamik Yürüyüş İndeksi (DGI) ve Türkçe versiyonu Tüm katılımcılara Mini Mental Durum Muayenesi (MMSE) uygulandı. bu Parkinson hastalığı anketi (PDQ‑39) ve Birleşik PD Derecelendirme Ölçeği sadece PD ve PSP'li hastalar arasında değerlendirildi. Sonuçlar: Önemli bir BBS, DGI ve PDQ‑39'un tüm değişkenleri açısından PD ve PSP arasındaki fark “sosyal destek” hariç (P < 0.05). önemli bir fark bulunsa da BBS ve DGI'de PSP'li ve HC'li hastalar arasında anlamlı bir DGI ve BBS'de PD ve HC'leri olan hastalar arasındaki fark. Ayrıca, BBS ve DGI, "hareketlilik" ve "faaliyetler" ile ilgili olarak güçlü bir şekilde ilişkilendirildi. PDQ‑39'un günlük yaşam" değişkenleri ve "toplam" açısından orta derecede korelasyon PDQ‑39”, “damgalama” ve “iletişim” alt puanları. MMSE "PDQ‑39 toplam puanları" ve "hareketlilik" alt puanı ile orta düzeyde ilişkilidir. Sonuç: Bu çalışma, denge, yürüme, ve PD ve HC'lere kıyasla PSP'li hastalarda yaşam kalitesi. Yine de, PH ve HC'li hastalar arasında fark yoktu. Anahtar Kelimeler: Denge, yürüyüş, idiyopatik Parkinson hastalığı, ilerleyici supranükleer felç, yaşam kalitesi

🔖

Cite This Article

ÇAKMUR, R., AKDAL, G., BOZ, H. E., KİRİŞ, A. Ö., KOÇOĞLU, K., ÇOLAKOĞLU, B. D. (2022). Balance and Gait Disturbances and Quality of Life in Patients with Idiopathic Parkinson’s Disease and Progressive Supranuclear Palsy. Neurological sciences and neurophysiology (Online), Cilt: 38 - Sayı: 1, 45–49. https://ajindex.com/articles/584320

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Keener AM, Bordelon YM. Parkinsonism. Semin Neurol 2016;36:330‑4
  2. Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem 2016;139 Suppl 1:318‑24
  3. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson’s disease: A prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721‑5
  4. Stolze H, Klebe S, Zechlin C, Baecker C, Friege L, Deushl G. Falls infrequent neurological diseases: Prevalence, risk factors and aetiology. J Neurol 2004;251:79‑84
  5. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP‑parkinsonism. Brain 2005;128:1247‑58
  6. Golbe LI. Progressive supranuclear palsy. Semin Neurol 2014;34:151‑9
  7. Chen H, Burton EA, Webster RG, Huang X, Savica R, Abbott RD, et al. Research on the premotor symptoms of Parkinson’s disease: Clinical and etiological implications. A review. Environ Health Perspect 2016;121:11‑2
  8. Pont‑Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord 2015;30:229‑37
  9. Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, et al. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord 2010;25:1077‑81
  10. Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, et al. Health‑related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 2011;8:438‑46
  11. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson’s disease: The relative importance of the symptoms. Mov Disord 2008;23:1428‑34
  12. Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. Health‑related quality of life in patients with progressive supranuclear palsy. Mov Disord 2003;18:1464‑9
  13. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson’s disease. J Neurol 2009;72:1‑136
  14. Egerton T, Williams DR, Iansek R. Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults. BMC Neurol 2012;12:116
  15. Soh SE, Morris ME, McGinley JL. Determinants of health‑related quality of life in Parkinson’s disease: A systematic review. Parkinsonism Relat Disord 2011;17:1‑9
  16. Rajiah